Guidance in topic selection
Showing 271 to 272 of 272
Title | Technology type | Decision | Decision date |
---|---|---|---|
Bifikafusp alfa–onfekafusp alfa for neoadjuvant treatment of 3B or 3C resectable melanoma [ID6384] | Medicine | Awaiting decision | TBC |
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with neurofibromatosis type 1 TS ID 11937 | Medicine | Awaiting decision | TBC |